They definitely do, which is why oncolytic virotherapy is not as simple as just direct oncolysis of tumor cells. It also relies on the highly immunogenic virus to attract T cells and other lymphocytes that may recognize the tumor to the microenvironment (antigen spreading).

It is also why these two modifications to our virus were chosen, integrins and retinoblastoma dysfunction are vital for a successful cancer cell.